Abstract: A system suitable for delivering a therapeutic agent to a target site may include a container for holding a therapeutic agent; a pressure source having pressurized fluid, the pressure source in selective fluid communication with at least a portion of the container; a catheter in selective fluid communication with the container and configured for delivery of the therapeutic agent or the pressurized fluid to a target site; and a housing configured to securely retain the container and movably support a switch, where the switch is movable between a first position and a second position, where when the switch is in the first position, delivery of the therapeutic agent is prevented while delivery of the pressurized fluid is permitted, and where when the switch is in the second position, delivery of the therapeutic agent is permitted.

Abstract: A system suitable for delivering a therapeutic agent to a target site may include a container for holding a therapeutic agent, a pressure source having pressurized fluid, where the pressure source is in selective fluid communication with at least a portion of the container, a catheter in selective fluid communication with the container and configured for delivery of the therapeutic agent to a target site, a first valve connected between the container and the catheter, a second valve connected between the pressure source and the container, a button configured to selectively actuate the second valve, and a brake assembly coupled to the first valve and configured to selectively permit actuation of the second valve, such that when the first valve is in a first state, the brake assembly blocks the button such that the button does not actuate the second valve.

Abstract: An angioplasty balloon (1) comprises an elongate tube (16) having a relaxed delivery configuration and an expanded deployed configuration. The elongate tube (16) comprises a proximal neck portion (10), a distal neck portion (8), a main body region, a tapered proximal portion (11) extending between the main body region and the proximal neck portion (10); and a tapered distal portion (9) extending between the main body region (3) and the distal neck portion (8), the elongate tube has only three fins (4, 5, 6) which are integrally formed with the tube and which are spaced equidistant from one another about the exterior of the tube. The fins (4, 5, 6) project radially outwardly from the exterior surface of the tube and the fins (4, 5, 6) extending longitudinally only along part of the main body region (3), resulting in the end-sections of the balloon main body being fin-free.

Abstract: A catheter (1) comprising an elongate tubular body (2) having a proximal end (3), a distal end (4), and an inner lumen (5) extending through the elongate tubular body (2), wherein the elongate tubular body (2) comprises a proximal section (6) and a distal section (7), wherein at least the proximal section (6) comprises at least two layers, wherein the proximal end (3) is connected with a catheter hub (8) being an adapter of greater radial outside dimension than the elongate tubular body (2), wherein the catheter hub (8) has an inner lumen (9) of larger inside diameter than the elongate tubular body (2), and wherein the innermost layer (10) of the proximal section (6) extends into the catheter hub (8) and flares from the proximal section (6) to the catheter hub (8). The catheter ensures a smooth transition of a medical device, e.g. a stent to be transferred from a storage device like a sheath into the tubular body of the catheter.

Abstract: A delivery system includes a catheter, and a drug coated angioplasty balloon mounted on the catheter. The balloon has a wrapped or folded delivery configuration and an expanded deployed configuration. A protective sleeve surrounds the drug coated balloon in the delivery configuration to minimise wash-off of drug from the balloon during delivery. The protective sleeve is retractable, so that once the drug coated balloon is at or near the treatment site, the sleeve can be retracted to allow the drug coated balloon to operate effectively. The protective sleeve can have a spacer mounted to or integral with the protective sleeve. The spacer in one case can comprise of interior ribs or ridges on the sleeve which minimise the surface area of the sleeve in direct contact with the drug coating on the balloon.

Abstract: An angioplasty balloon (1) comprises an elongate tube (16) having a relaxed delivery configuration and an expanded deployed configuration. The elongate tube (16) comprises aproximal neck portion (10), a distal neck portion (8), a main body region, a tapered proximal portion (11) extending between the main body region and the proximal neck portion (10); and a tapered distal portion (9) extending between the main body region (3) and the distal neck portion (8), the elongate tube has only three fins (4, 5, 6) which are integrally formed with the tube and which are spaced equidistant from one another about the exterior of the tube. The fins (4, 5, 6) project radially outwardly from the exterior surface of the tube and the fins (4, 5, 6) extending longitudinally only along part of the main body region (3), resulting in the end-sections of the balloon main body being fin-free.

Abstract: A catheter (1) comprising an elongate tubular body (2) having a proximal end (3), a distal end (4), and an inner lumen (5) extending through the elongate tubular body (2), wherein the elongate tubular body (2) comprises a proximal section (6) and a distal section (7), wherein at least the proximal section (6) comprises at least two layers, wherein the proximal end (3) is connected with a catheter hub (8) being an adapter of greater radial outside dimension than the elongate tubular body (2), wherein the catheter hub (8) has an inner lumen (9) of larger inside diameter than the elongate tubular body (2), and wherein the innermost layer (10) of the proximal section (6) extends into the catheter hub (8) and flares from the proximal section (6) to the catheter hub (8). The catheter ensures a smooth transition of a medical device, e.g. a stent to be transferred from a storage device like a sheath into the tubular body of the catheter.

Abstract: A delivery system includes a catheter, and a drug coated angioplasty balloon mounted on the catheter. The balloon has a wrapped or folded delivery configuration and an expanded deployed configuration. A protective sleeve surrounds the drug coated balloon in the delivery configuration to minimise wash-off of drug from the balloon during delivery. The protective sleeve is retractable, so that once the drug coated balloon is at or near the treatment site, the sleeve can be retracted to allow the drug coated balloon to operate effectively. The protective sleeve can have a spacer mounted to or integral with the protective sleeve. The spacer in one case can comprise of interior ribs or ridges on the sleeve which minimise the surface area of the sleeve in direct contact with the drug coating on the balloon.

Abstract: A stent delivery system configured to deliver a stent to a target region of a body lumen may include a catheter; a stent associated with the catheter, the stent having a first region and a second region; a balloon associated with the catheter, the balloon having a first balloon portion associated with the catheter proximate the first region of the stent and a second balloon portion associated with the catheter proximate the second region of the stent; and a sheath about the stent and the balloon, the sheath maintaining the stent in an undeployed configuration for delivery to a target region of a body lumen.

Abstract: A delivery system for delivering a self-expanding medical device such as a stent. The delivery system includes a sheath profiled or shaped to reduce instances of interference between a distal edge of the sheath and a vessel or with any lesion or lesions that might be present in the vessel. The sheath is formed by modifying a cylinder of sheath material to include three portions and an initiation slit that controls the rupturing of the sheath to facilitate delivery of the medical device. The initiation slit is positioned on the delivery system with respect to a configuration of a balloon portion of the system.

Abstract: A stent delivery system configured to deliver a stent to a target region of a body lumen may include a catheter; a stent associated with the catheter, the stent having a first region and a second region; a balloon associated with the catheter, the balloon having a first balloon portion associated with the catheter proximate the first region of the stent and a second balloon portion associated with the catheter proximate the second region of the stent; and a sheath about the stent and the balloon, the sheath maintaining the stent in an undeployed configuration for delivery to a target region of a body lumen.

Abstract: A medical device delivery system provides for a two-stage withdrawal of a deflated balloon portion of a catheter and the remains of a ruptured sheath. The deflated balloon portion is withdrawn from within an expanded medical device a predetermined distance before the remains of the ruptured sheath begins being removed from between the expanded device and a vessel wall. Initiating removal of the deflated balloon portion before the sheath reduces a total amount of drag that is exerted against a self-expanding medical device that has been deployed in a vessel.

Abstract: A delivery system for delivering a self-expanding medical device such as a stent. The delivery system includes a sheath profiled or shaped to reduce instances of interference between a distal edge of the sheath and a vessel or with any lesion or lesions that might be present in the vessel. The sheath is formed by modifying a cylinder of sheath material to include three portions and an initiation slit that controls the rupturing of the sheath to facilitate delivery of the medical device. The initiation slit is positioned on the delivery system with respect to a configuration of a balloon portion of the system.

Abstract: A device for implantation in a vessel is provided with a geometry designed to reduce the drag experienced by the device when deployed using a sheathed delivery system. Sections of the device are provided with regions of high-points and low-points on the device's outer surface by curving one or more of the struts of the device. The high points serve as the contact points of the device with the sheath as the sheath and the delivery system are withdrawn from between the device and the vessel.

Abstract: A medical device delivery system provides for a two-stage withdrawal of a deflated balloon portion of a catheter and the remains of a ruptured sheath. The deflated balloon portion is withdrawn from within an expanded medical device a predetermined distance before the remains of the ruptured sheath begins being removed from between the expanded device and a vessel wall. Initiating removal of the deflated balloon portion before the sheath reduces a total amount of drag that is exerted against a self-expanding medical device that has been deployed in a vessel.

Abstract: A medical device delivery system includes a self-expanding medical device mounted on a balloon portion of a catheter. A sheath is provided around the medical device to hold the device in place with the device staying in a compressed state. A series of perforations or an initial cut is provided in the sheath at a predetermined location, or within a predetermined range of locations, on the circumference of the sheath. The predetermined location or range of locations are determined with respect to the folds of the balloon portion.